Latest Orphai Therapeutics News & Updates

See the latest news and media coverage for Orphai Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Orphai Therapeutics

Biotech developing treatments for pulmonary diseases

orphai-therapeutics.com
Headquarters
New Haven, United States
Founded year
2013
Company type
Private company
Number of employees
2–15

Last updated

Latest news about Orphai Therapeutics

In short: OrphAI Therapeutics was acquired by Quince Therapeutics and secured a $187 million placement to advance its pulmonary drug pipeline.

Company announcements

Orphai Therapeutics

OrphAI Therapeutics initiates Phase II LAM-001 trial for PAH

The 24-week, single-arm study evaluates safety, tolerability, and activity in 15 adults with advanced PAH on background therapy. Endpoints include VO2 max and hemodynamic metrics.

Unlock all announcements with a

Media coverage

Yahoo Finance

OrphAI Therapeutics receives Orphan Drug Designation for AIT-101 as a treatment for amyotrophic lateral sclerosis in the European Union

GUILFORD, Conn., Feb. 15, 2024 (GLOBE NEWSWIRE) -- OrphAI Therapeutics Inc. ("OrphAI"), a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today that...

Unlock all articles with a

Never miss news about Orphai Therapeutics

Track Orphai Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Orphai Therapeutics competitors & trending companies

Browse news for competitors to Orphai Therapeutics and other trending companies.